欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
It is recommended that quadrivalent vaccines for use in the 2023 southern hemisphere influenza season contain the following: Egg-based vaccines• an A/Sydney/5/2021 (H1N1)pdm09-like virus; • an A/Darwin/9/2021 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Cell culture- or recombinant-based vaccines• an A/Sydney/5/2021 (H1N1)pdm09-like virus; • an A/Darwin/6/2021 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. It is recommended that trivalent vaccines for use in the 2023 southern hemisphere influenza season contain the following:
Egg-based vaccines• an A/Sydney/5/2021 (H1N1)pdm09-like virus; • an A/Darwin/9/2021 (H3N2)-like virus; and • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus. Cell culture- or recombinant-based vaccines
• an A/Sydney/5/2021 (H1N1)pdm09-like virus; • an A/Darwin/6/2021 (H3N2)-like virus; and • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus
|